Dear Doctor - Participate in the Survey on fecal microbiota transplantation "Fecal microbiota transplantation (FMT) is a procedure in which stool from a healthy donor is transplanted into the gastrointestinal tract of a person with a gut disorder. The goal of FMT is to restore the composition and function of the gut microbiome.Research on FMT is still in its early stages, but preliminary studies suggest that it may be an effective treatment for a variety of gut disorders, including Clostridium difficile infection (CDI), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). In addition, because the gut microbiome plays a role in immunity, there is interest in using FMT as a treatment for autoimmune diseases such as Crohn's disease and type 1 diabetes.Side effects of FMT are generally minor and include abdominal pain, bloating, diarrhea, and constipation. However, serious complications have been reported in rare cases, such as sepsis (a potentially life-threatening condition caused by infection).If you are considering FMT for yourself or a loved one, it is important to speak with a healthcare provider who is experienced in this procedure. Participate in Surveys "
1.
enhancing survivors of brain tumors' quality of life.
2.
Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.
3.
A protein with new anticancer activity has been identified
4.
Studies point to redlining as a 'perfect storm' for breast cancer
5.
Enzalutamide vs Abiraterone: Which is Better for mCSPC?
1.
From Diagnosis to Recovery: A Comprehensive Guide to Dealing with Cystic Teratoma
2.
Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care
3.
What is Hemorrhagic Cystitis and How to Manage its Symptoms
4.
Fc Receptor Mediated Pharmacology of Therapeutic Antibodies
5.
Progressive Strategies in Oncology and Patient Outcomes
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
4.
Managing Common Side Effects During Cancer Treatment
5.
Clinical Insights in Oncology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation